NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1679660021 M.D.
Verify on CMS → Michael Imevbore, M.D.
Pulmonary Disease Physician in New Haven, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 1K beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
0%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.2/100
▲ 11 pts above national avg 83.1 · Exceptional
Industry payments
$34.8K
130 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Michael Imevbore, M.D. reported a CMS MIPS final score of 94.2/100 - above the 83.1 national average - and filed 5,355 Medicare Part D claims in 2023.
- 94.2/100
- MIPS score · +11 vs avg
- 5K
- Part D claims, 2023
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Imevbore, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
94 Top 25% higher than 75% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Imevbore, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Imevbore, M.D. writes more Part D claims than 95% of them and scores higher on MIPS quality than 76% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Michael Imevbore, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Imevbore, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Imevbore, M.D.?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
5,355 268% vs specialty avg
MIPS final score
94.2/100 11.1 pts vs avg
Specialty distribution in Connecticut
How Pulmonary Disease Physician compares to other specialties among Connecticut providers
Medicare quality performance, MIPS
Michael Imevbore, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 94.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 94.2/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Imevbore, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 46 PRINCE ST, New Haven, CT, 06519, with a listed phone of (203) 786-5067. NPI 1679660021 was issued on 10/06/2006.
Medicare Part D records for calendar year 2023 show 5,355 prescription claims written by this provider, covering 1,035 Medicare beneficiaries and totaling roughly $4.1 million in drug spend, split 62% brand-name and 0% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.2/100 for the 2023 performance year (Quality 81.9), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679660021 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/06/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
94.1777
Final Score
Avg: 83.1
81.9442
Quality
99.3986
Promoting Interoperability
Reporting: Alternative Payment Model
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Imevbore, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$34.8K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Michael Imevbore, M.D. - brand share 62.0%
Pulmonary Disease Physician average
62% brand-name claims vs 0% generic, on 5,355 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
5,355
Total Claims
$4.1M
Total Drug Cost
1,035
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,729
- Total Day Supply
- 246,652
- Brand vs Generic
- 62% brand / 0% generic
- Brand Drug Cost
- $4.0M
- Antibiotic Claims
- 170
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.99
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 163, 65-74: 399, 75-84: 361, 85+: 112
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Imevbore, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
1,358 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
634 claims
- Montelukast Sodium 541
Montelukast Sodium
541 claims
- Prednisone 380
Prednisone
380 claims
- Anoro Ellipta 308
Anoro Ellipta
308 claims
- Pantoprazole Sodium 234
Pantoprazole Sodium
234 claims
- Breztri Aerosphere 223
Breztri Aerosphere
223 claims
- Symbicort 202
Symbicort
202 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,358 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 634 |
| Montelukast Sodium | 541 |
| Prednisone | 380 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 308 |
| Pantoprazole Sodium | 234 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 223 |
| Symbicort Budesonide/Formoterol Fumarate | 202 |
| Breo Ellipta Fluticasone/Vilanterol | 161 |
| Ventolin Hfa Albuterol Sulfate | 118 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Michael Imevbore, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Michael Imevbore, M.D.'s 5,355 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Imevbore.
Dr. Mubdiul Ali
M.D.
New Haven, CT
Dr. Naser Adeeb Aljundi
MD
New London, CT
Dr. Augustine Andoh-Duku
M.D
Danbury, CT
Dr. Mohammed Anwar
MD
Vernon, CT
Dr. Mircea Badara
M.D.
New Britain, CT
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Connecticut
Frequently Asked Questions
What is Michael Imevbore, M.D.'s specialty? ▼
Michael Imevbore, M.D. specializes in Pulmonary Disease Physician and practices in New Haven, Connecticut. Credentials: M.D..
How much does Michael Imevbore, M.D. prescribe under Medicare Part D? ▼
In 2023, Michael Imevbore, M.D. wrote 5,355 Medicare Part D claims totaling $4.1M in drug costs for 1,035 beneficiaries.
What is Michael Imevbore, M.D.'s Medicare quality score? ▼
Michael Imevbore, M.D. has a CMS MIPS Final Score of 94.2/100 (Quality: 81.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Imevbore, M.D. located? ▼
Michael Imevbore, M.D. is located at 46 PRINCE ST, New Haven, CT, 06519. Phone: (203) 786-5067.
What is Michael Imevbore, M.D.'s NPI number? ▼
Michael Imevbore, M.D.'s National Provider Identifier (NPI) is 1679660021, issued on 10/06/2006.
Does Michael Imevbore, M.D. prescribe more brand-name or generic drugs? ▼
Michael Imevbore, M.D.'s prescribing is 62% brand-name and 0% generic drugs by claim count, with $4.0M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Michael Imevbore, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Imevbore, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Imevbore, M.D. accept Medicare? ▼
Michael Imevbore, M.D. appears in CMS Medicare data with 5,355 Part D claims and 1,035 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Imevbore, M.D.'s credentials? ▼
Michael Imevbore, M.D.'s NPI is 1679660021 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.